The Graduate Research Fellowship in Toxicology from Bristol-Myers Squibb Co. (BMS) supports students involved in non-clinical, in vivo toxicology research. Fifth year Ph.D. candidate Rulaiha E. Taylor was selected as the 2022-2023 recipient of this prestigious fellowship. Her research focuses on studying the development and progression of non-alcoholic steatohepatitis (NASH) in a novel low bile acid animal model with a specific focus on bile acid dysregulation and the nuclear and membrane receptor farnesoid x receptor (FXR). The overall goal of her research is to characterize the effects of individual bile acids on the onset of inflammatory and oxidative stress responses during NASH pathogenesis. These findings may provide novel therapeutic targets for drug development and biomarker discovery for NASH patients. The BMS Fellowship will support Rulaiha’s research costs, stipend, and allow for personalized mentoring from expert scientists at Bristol-Myers Squibb. Congratulations, Rulaiha! We are so proud of you!